Which has grown faster, CCCC or ENTA?

Over the past five years, CCCC grew revenue faster — CCCC at a 0.65% CAGR versus ENTA at -7.65%.

How have CCCC and ENTA total returns compared?

Over the past 5 years, CCCC delivered -41.77% and ENTA delivered -26.94% annualized total return. Past performance doesn't predict future results.

C4 Therapeutics, Inc. (CCCC) vs Enanta Pharmaceuticals, Inc. (ENTA)

A side-by-side comparison of C4 Therapeutics, Inc. and Enanta Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CCCC

C4 Therapeutics, Inc.

$325M

$2.94HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT

ENTA

Enanta Pharmaceuticals, Inc.

$351M

$12.06HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT

Total return — CCCC vs ENTA

growth of $100 · dividends reinvested · last 6y

CCCC -88.3% (-30.0%/yr)ENTA -72.5% (-19.3%/yr)ENTA compounded faster over this window

CCCC ENTA

CCCC vs ENTA: by the numbers

•ENTA is the larger company ($351M vs $325M market cap).
•Both run net losses; ENTA's is the smaller (-96.89% vs -289.44% net margin).
•CCCC grew revenue faster over the past five years (0.65% vs -7.65% CAGR).

Metrics side by side

Valuation

Metric	CCCC	ENTA
P/S ratio	9.26	5.37
P/B ratio	1.31	3.47

Profitability

Metric	CCCC	ENTA
Gross margin	77.81%	98.15%
Operating margin	-290.68%	-130.65%
Net margin	-289.44%	-96.89%
ROE	-41.02%	-62.56%
ROIC	-35.92%	-24.20%

Growth (annualized)

Metric	CCCC	ENTA
Revenue CAGR (5Y)	0.65%	-7.65%
Total return CAGR (5Y)	-41.77%	-26.94%

Frequently asked

Which has grown faster, CCCC or ENTA?: Over the past five years, CCCC grew revenue faster — CCCC at a 0.65% CAGR versus ENTA at -7.65%.
How have CCCC and ENTA total returns compared?: Over the past 5 years, CCCC delivered -41.77% and ENTA delivered -26.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CCCC analysis Full ENTA analysis Interactive comparison tool

Dig into the metrics

C4 Therapeutics ROE Enanta Pharmaceuticals ROE C4 Therapeutics operating margin Enanta Pharmaceuticals operating margin C4 Therapeutics revenue growth Enanta Pharmaceuticals revenue growth C4 Therapeutics free cash flow Enanta Pharmaceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.